# FDA recall D-0560-2023

> **PD-Rx Pharmaceuticals, Inc.** · Class II · drug recall initiated 2023-04-06.

## Product

Simvastatin USP 20 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127 a) 30 count-bottles (NDC 43063-008-30), b) 90 count-bottles (NDC: 43063-0008-90)

## Reason for recall

CGMP deviations.

## Distribution

Nationwide in the US.

## Key facts

- **Recall number:** D-0560-2023
- **Recalling firm:** PD-Rx Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-04-06
- **Report date:** 2023-05-10
- **Termination date:** 2024-04-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Oklahoma City, OK, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0560-2023

## Citation

> AI Analytics. FDA recall D-0560-2023. Retrieved 2026-06-24 from https://api.ai-analytics.org/recall/D-0560-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*